Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Research Paper

Expression of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN/CD147) in Pancreatic Neoplasm and Pancreatic Stellate Cells

Weiwei Zhang, Mert Erkan, Ivane Abiatari, Nathalia A. Giese, Klaus Felix, Hany Kayed, Markus W. Buchler and Jörg Kleeff

volume 6 | issue 2

February 2007
Pages: 218 - 227

This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

EMMPRIN (extracellular matrix metalloproteinase inducer, CD147) participates in the progression of various malignancies by stimulating the synthesis of specific matrix metalloproteinases (MMP) from peritumoral fibroblasts. In the present study, the expression and functional role of EMMPRIN was investigated in pancreatic neoplasm. QRT-PCR, immunohistochemistry, immunoblot, and ELISA analyses were used to analyze the expression, localization, and release of EMMRPIN. Silencing of EMMPRIN was performed using siRNA oligonucleotides, and functional consequences were assessed using growth assays, invasion assays, as well as MMP1/MMP2 and VEGF ELISA. EMMPRIN mRNA levels were 2.2-fold increased in pancreatic cancer (n=52) and 2.0-3.5-fold increased in other pancreatic neoplasm (n=105), but unchanged in chronic pancreatitis (n=10) compared to normal pancreatic tissues (n=9). Strong and predominantly membranous immunostaining was observed in the cancer cells and surrounding stromal cells. EMMPRIN serum levels were also significantly increased in pancreatic cancer patients (n=44) (4.13 +/- 0.28 ng/ml) with an AUC of 0.97 compared to healthy volunteers (n=29) (0.95 +/- 0.16 ng/ml; p<0.0001) and with an AUC of 0.74 compared to chronic pancreatitis patients (n=20) (2.98 +/- 0.5 ng/ml; p=0.0021). EMMPRIN silencing did not significantly affect anchorage-dependent or -independent growth of pancreatic cancer cells. In contrast, EMMPRIN silencing in pancreatic stellate cells slightly repressed VEGF and MMP2 levels but strongly increased pro-MMP1 expression under co-culture conditions. In conclusion, Increased EMMPRIN expression is present in different pancreatic neoplasm, likely representing a tumor-specific reaction with the potential to modulate the tumor microenvironment rather than a mere reflection of an activated stroma.

Authors

Weiwei Zhang

University of Heidelberg, Heidelberg, Germany

Mert Erkan

University of Heidelberg, Heidelberg, Germany

Ivane Abiatari

University of Heidelberg, Heidelberg, Germany

Nathalia A. Giese

University of Heidelberg, Heidelberg, Germany

Klaus Felix

University of Heidelberg, Heidelberg, Germany

Hany Kayed

University of Heidelberg, Heidelberg, Germany

Markus W. Buchler

University of Heidelberg, Heidelberg, Germany

Jörg Kleeff

University of Heidelberg, Heidelberg, Germany


This is an open-access article

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.